AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine
COVID-19: Updates from AMRI
Request a quote for:
- Analytical Services
- in vitro DMPK Services
- Aseptic Fill Finish Services
- Antimicrobial discovery testing services
Submit Samples For Analytical Testing
Learn more about the sample studies we perform and reports we provide.
Navigate the Journey From Pipeline to Portfolio With a Trusted Partner.See our solutions
The Latest from AMRI
October 14, 2020
ALBANY, N.Y.–(BUSINESS WIRE)–Albany Molecular Research, Inc., (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today...
October 13, 2020
DANVILLE, Calif.–(BUSINESS WIRE)–BryoLogyx, Inc., today announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing...
September 3, 2020
AMRI’s Albuquerque Facility Is Set to Provide Sterile Fill/Finish Manufacture of AstraZeneca’s AZD1222 Vaccine Candidate Through 2021 ALBANY, N.Y.–(BUSINESS...
August 13, 2020
La Jolla, California–(Newsfile Corp. – August 13, 2020) – Tryp Therapeutics Inc. (“Tryp” or the “Company”), a clinical-stage pharmaceutical company...